OverviewSuggest Edit

Solutions with you in mind. At Almirall, we dedicate ourselves to finding real solutions for real needs. Our mission is to provide valuable medicines and medical devices to you and future generations. To do this, we complement our extensive research and development programme with a strategic partner network, while remaining firmly connected to all those whose lives we touch.
TypePublic
Founded1943
HQBarcelona, ES
Websitealmirall.com

Latest Updates

Employees (est.) (May 2021)1,787(-1%)
Share Price (Jun 2021)€14.3
Cybersecurity ratingBMore

Key People/Management at Almirall

Antonio Gallardo Torrededía

Antonio Gallardo Torrededía

Director, Secretary
Alfredo Barón de Juan

Alfredo Barón de Juan

Executive Vice-President, Global Commercial Operations
Tom McKillop

Tom McKillop

Vicechairman and External Director
Carlos Gallardo Piqué

Carlos Gallardo Piqué

Director
Gerhard Mayr

Gerhard Mayr

Chairman
Bhushan Hardas

Bhushan Hardas

Executive Vice-President R&D and Chief Scientific Officer
Show more

Almirall Office Locations

Almirall has an office in Barcelona
Barcelona, ES (HQ)
151 Ronda del General Mitre
Show all (1)

Almirall Financials and Metrics

Almirall Revenue

Market capitalization (4-Jun-2021)

2.5b

Closing stock price (4-Jun-2021)

14.3
Almirall's current market capitalization is €2.5 b.
Show all financial metrics

Almirall Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Almirall Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Almirall Online and Social Media Presence

Embed Graph

Almirall News and Updates

Almirall receives positive CHMP opinion for Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis

BARCELONA, Spain, May 21, 2021 /PRNewswire/ -- Almirall S.A. (BME: ALM), a global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the regulatory approval of...

Almirall U.S. Launches Klisyri® (tirbanibulin), a New, Innovative Topical Treatment for Actinic Keratosis

EXTON, Pa., Feb. 18, 2021 /PRNewswire/ -- Almirall, S.A. (BME:ALM), a global biopharmaceutical company focused on skin health, announced today the U.S. commercial launch of Klisyri® (tirbanibulin), developed for the topical treatment of actinic keratosis (AK) of the face and scalp....

Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis

BARCELONA, Spain and COPENHAGEN, Denmark, Feb. 17, 2021 /PRNewswire/ -- Almirall S.A. (BME: ALM), a global biopharmaceutical company and MC2 Therapeutics, a commercial stage pharmaceutical company developing a new standard within topical therapies for autoimmune and chronic inflammatory...

Almirall and Happify Health enter into strategic partnership to develop evidence-supported digital therapeutics solutions for psoriasis patients

BARCELONA, Jan. 28, 2021 /PRNewswire/ -- Almirall, S.A. (BME:ALM), a global biopharmaceutical company based in Barcelona, and Happify Health, a leader in digital therapeutics solutions to improve mental and physical health based in New York, will develop a version of its digital platform...

Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis

EXTON, Pa., Dec. 15, 2020 /PRNewswire/ -- Almirall, S.A. (BME:ALM), a global biopharmaceutical company focused on skin health, announced today that Klisyri® (tirbanibulin) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis (AK)...

Pablo Alvarez appointed to President and GM of Almirall US

BARCELONA, Spain, Nov. 11, 2020 /PRNewswire/ -- Almirall, S.A. (ALM) the global biopharmaceutical company based in Barcelona, has announced that Pablo Alvarez has been promoted and will become the new President & GM of Almirall US, reporting directly to the CEO and serving on the...
Show more

Almirall Frequently Asked Questions

  • When was Almirall founded?

    Almirall was founded in 1943.

  • Who are Almirall key executives?

    Almirall's key executives are Antonio Gallardo Torrededía, Alfredo Barón de Juan and Tom McKillop.

  • How many employees does Almirall have?

    Almirall has 1,787 employees.

  • Who are Almirall competitors?

    Competitors of Almirall include Teva, Takeda and KRKA.

  • Where is Almirall headquarters?

    Almirall headquarters is located at 151 Ronda del General Mitre, Barcelona.

  • Where are Almirall offices?

    Almirall has an office in Barcelona.

  • How many offices does Almirall have?

    Almirall has 1 office.